Literature DB >> 33643910

Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy.

Paul Sargos1, Nicolas Leduc1, Nicolas Giraud2, Giorgio Gandaglia3, Mathieu Roumiguié4, Guillaume Ploussard5, Francois Rozet6, Michel Soulié4, Romain Mathieu7, Pierre Mongiat Artus8, Tamim Niazi2, Vincent Vinh-Hung9, Jean-Baptiste Beauval4.   

Abstract

BACKGROUND: Use of predictive models for the prediction of biochemical recurrence (BCR) is gaining attention for prostate cancer (PCa). Specifically, BCR occurs in approximately 20-40% of patients five years after radical prostatectomy (RP) and the ability to predict BCR may help clinicians to make better treatment decisions. We aim to investigate the accuracy of CAPRA score compared to others models in predicting the 3-year BCR of PCa patients.
MATERIAL AND METHODS: A total of 5043 men who underwent RP were analyzed retrospectively. The accuracy of CAPRA score, Cox regression analysis, logistic regression, K-nearest neighbor (KNN), random forest (RF) and a densely connected feed-forward neural network (DNN) classifier were compared in terms of 3-year BCR predictive value. The area under the receiver operating characteristic curve was mainly used to assess the performance of the predictive models in predicting the 3 years BCR of PCa patients. Pre-operative data such as PSA level, Gleason grade, and T stage were included in the multivariate analysis. To measure potential improvements to the model performance due to additional data, each model was trained once more with an additional set of post-operative surgical data from definitive pathology.
RESULTS: Using the CAPRA score variables, DNN predictive model showed the highest AUC value of 0.7 comparing to the CAPRA score, logistic regression, KNN, RF, and cox regression with 0.63, 0.63, 0.55, 0.64, and 0.64, respectively. After including the post-operative variables to the model, the AUC values based on KNN, RF, and cox regression and DNN were improved to 0.77, 0.74, 0.75, and 0.84, respectively.
CONCLUSIONS: Our results showed that the DNN has the potential to predict the 3-year BCR and outperformed the CAPRA score and other predictive models.
Copyright © 2021 Sargos, Leduc, Giraud, Gandaglia, Roumiguié, Ploussard, Rozet, Soulié, Mathieu, Artus, Niazi, Vinh-Hung and Beauval.

Entities:  

Keywords:  biochemical; machine learning; predictive; prostate cancer; recurrence

Year:  2021        PMID: 33643910      PMCID: PMC7906005          DOI: 10.3389/fonc.2020.607923

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  23 in total

1.  The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

Authors:  Matthew R Cooperberg; Joan F Hilton; Peter R Carroll
Journal:  Cancer       Date:  2011-06-03       Impact factor: 6.860

2.  Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.

Authors:  Timothy J Wilt; Karen M Jones; Michael J Barry; Gerald L Andriole; Daniel Culkin; Thomas Wheeler; William J Aronson; Michael K Brawer
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

Review 3.  Deep learning for healthcare: review, opportunities and challenges.

Authors:  Riccardo Miotto; Fei Wang; Shuang Wang; Xiaoqian Jiang; Joel T Dudley
Journal:  Brief Bioinform       Date:  2018-11-27       Impact factor: 11.622

4.  A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

Authors:  Zachary S Zumsteg; Daniel E Spratt; Isaac Pei; Zhigang Zhang; Yoshiya Yamada; Marisa Kollmeier; Michael J Zelefsky
Journal:  Eur Urol       Date:  2013-03-23       Impact factor: 20.096

Review 5.  A new era: artificial intelligence and machine learning in prostate cancer.

Authors:  S Larry Goldenberg; Guy Nir; Septimiu E Salcudean
Journal:  Nat Rev Urol       Date:  2019-07       Impact factor: 14.432

6.  The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.

Authors:  D P Lubeck; M S Litwin; J M Henning; D M Stier; P Mazonson; R Fisk; P R Carroll
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

Review 7.  Prostate-specific antigen doubling time as a prognostic marker in prostate cancer.

Authors:  James A Eastham
Journal:  Nat Clin Pract Urol       Date:  2005-10

8.  Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy.

Authors:  Nathan C Wong; Cameron Lam; Lisa Patterson; Bobby Shayegan
Journal:  BJU Int       Date:  2018-08-05       Impact factor: 5.588

9.  Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma.

Authors:  Ahmad Chaddad; Paul Daniel; Siham Sabri; Christian Desrosiers; Bassam Abdulkarim
Journal:  Cancers (Basel)       Date:  2019-08-10       Impact factor: 6.639

10.  Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.

Authors:  Claire L Vale; David Fisher; Andrew Kneebone; Christopher Parker; Maria Pearse; Pierre Richaud; Paul Sargos; Matthew R Sydes; Christopher Brawley; Meryem Brihoum; Chris Brown; Sylvie Chabaud; Adrian Cook; Silvia Forcat; Carol Fraser-Browne; Igor Latorzeff; Mahesh K B Parmar; Jayne F Tierney
Journal:  Lancet       Date:  2020-09-28       Impact factor: 79.321

View more
  2 in total

1.  Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence.

Authors:  Nicolas Giraud; Xavier Buy; Nam-Son Vuong; Richard Gaston; Anne-Laure Cazeau; Vittorio Catena; Jean Palussiere; Guilhem Roubaud; Paul Sargos
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

2.  A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy.

Authors:  Steven N Seyedin; John M Watkins; Zachary Mayo; Anthony N Snow; Michael Laszewski; J Kyle Russo; Sarah L Mott; Chad R Tracy; Mark C Smith; John M Buatti; Joseph M Caster
Journal:  Adv Radiat Oncol       Date:  2021-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.